antiviral drug

An envelope with rejected mark Vector illustration
Manufacturing

Manufacturing issues prompt FDA rejection of Hyloris antiviral

The FDA has rejected Hyloris' antiviral valacyclovir, an oral suspension for infections caused by herpes simplex, because of manufacturing issues.
Kevin Dunleavy Mar 13, 2026 8:40am
HIV AIDS PREP
Favicon Fierce Biotech

Study finds HIV can evolve to resist lenacapavir—at a cost

Jan 7, 2026 2:00pm
An artists concept of different strains or types of coronaviruses shown in multiple bright colors against a teal background

Shionogi's antiviral comes up short in global COVID-19 trial

May 13, 2024 10:48am
Pfizer

Pfizer's Paxlovid access questioned ahead of WTO patent talks

Nov 21, 2022 11:41am
Gilead Sciences

FDA swats away Gilead's hepatitis D treatment bulevirtide

Oct 28, 2022 9:52am
Gilead

Gilead plots pivotal clinical trial for COVID oral antiviral

Oct 19, 2022 12:01am